Versant Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.36K	Buy	214 +126	+143%	+$2.56K	﹤0.01%	2206
2025 Q1	$1.6K	Buy	+88	New	+$1.6K	﹤0.01%	2301
2024 Q4	–	Sell	-92	Closed	-$3.13K	–	2386
2024 Q3	$3.13K	Buy	+92	New	+$3.13K	﹤0.01%	1432